ArticleCancer medicine2025

Cannabinoid Receptor Type 2 Agonist, GW405833, Reduced the Impacts of MDA-MB-231 Breast Cancer Cells on Bone Cells.

Ingon Inson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.